Endoscopic ultrasound guided hepatico‐gastrictubestomy for bile duct stent obstruction in a patient with recurrent cancer after esophageal cancer surgery with gastric tube reconstruction

2020 ◽  
Author(s):  
Kosuke Maehara ◽  
Susumu Hijioka ◽  
Yutaka Saito

Suizo ◽  
2020 ◽  
Vol 35 (5) ◽  
pp. 378-386
Author(s):  
Ryosuke ARATA ◽  
Yasuhiro MATSUGU ◽  
Akihiko OSHITA ◽  
Tamito SASAKI ◽  
Hideki NAKAHARA ◽  
...  


2018 ◽  
Vol 38 (8) ◽  
pp. 4941-4945 ◽  
Author(s):  
TOMOKI KONISHI ◽  
ATSUSHI SHIOZAKI ◽  
HITOSHI FUJIWARA ◽  
HIROTAKA KONISHI ◽  
KENICHI TAKEMOTO ◽  
...  


1996 ◽  
Vol 29 (3) ◽  
pp. 722-726 ◽  
Author(s):  
Yoshihiro Kagawa ◽  
Wataru Takiyama ◽  
Toshiaki Saeki ◽  
Shigemitsu Takashima ◽  
Kouichi Manadai


2020 ◽  
Vol 50 (5) ◽  
pp. 602-608 ◽  
Author(s):  
Jun Chi ◽  
Shan-shan Lian ◽  
Qing Yang ◽  
Guang-yu Luo ◽  
Guo-Liang Xu

Abstract Objectives Postoperative recurrences, especially anastomotic recurrence and regional lymph node recurrence were common in patients even with curative esophageal cancer surgery. Endobronchial ultrasound-guided transbronchial needle aspiration is an alternative to mediastinoscopy in patients with lung cancer and mediastinal lymphadenopathy. The aim of our study is to evaluate the utility of endobronchial ultrasound-guided transbronchial needle aspiration in postoperative patients suffered from esophageal malignancy. Methods All endobronchial ultrasound-guided transbronchial needle aspiration cases performed between August 2015 and December 2018 in our center were all retrospective reviewed. The patients with enlarged mediastinal lymph node and/or unknown intrathoracic mass after esophageal cancer surgery were enrolled. Final diagnoses were determined by the result of endobronchial ultrasound-guided transbronchial needle aspiration, second surgery and/or clinical follow-up for at least 6 months. Results Overall 29 patients were included in the analysis with 30 lesions sampled. No endobronchial ultrasound-guided transbronchial needle aspiration related complications were observed. In total, 22 of these (73.3%) had a diagnosis of tumor recurrence, whereas eight (26.7%) had a different diagnosis: two (6.7%) had a second primary malignancy and three (10.0%) had non-neoplastic diagnosis. Cases were false-negative in 3 (10.0%) out of 30 lesions. The overall sensitivity, negative predicted value and diagnostic accuracy were 88.9, 50.0 and 90.0%, respectively. Conclusions Given its safety, low invasiveness, high sensitivity and diagnostic accuracy, endobronchial ultrasound-guided transbronchial needle aspiration could be considered for mediastinal lymphadenopathy and intrathoracic masses of unknown origin in patients after radical esophageal cancer resection, and its strategic role in the management of these patients was confirmed.





2020 ◽  
Vol 71 (4) ◽  
pp. 319-324
Author(s):  
Shunsuke Ohta ◽  
Hideaki Motohashi ◽  
Hirotoshi Kobayashi




Sign in / Sign up

Export Citation Format

Share Document